+ -Text Size

The National HPV Vaccination Roundtable

HPV Image

The National HPV Vaccination Roundtable, established by the American Cancer Society (ACS) and the Centers for Disease Control and Prevention (CDC) in 2014, is a national coalition of public organizations, private organizations, voluntary organizations, and invited individuals dedicated to reducing the incidence of and mortality from HPV-associated cancer in the U.S., through coordinated leadership and strategic planning. The ultimate goal of the Roundtable is to reduce the number of HPV-associated cancers and cervical precancerous lesions as well as non-cancer outcomes through (1) increased frequency and strength of clinician recommendations for HPV vaccine, (2) decreased missed opportunities for HPV vaccine administration, and (3) increased HPV vaccination rates at national and state levels, with a focus on girls and boys ages 11-12. .


HPV Vaccination and Cancer

Nearly all cases of cervical cancer are caused by infection with high-risk types of human papilloma virus (HPV). The virus also has been linked to cancers of the vagina, vulva, anus, penis, and throat. HPV vaccination prevents infection by virus types that cause the vast majority of these cancers and genital warts, but the vaccine works only if given well before an infection occurs. That’s why, in part, the American Cancer Society recommends it at ages 11 to 12.
Vaccination at these younger ages also leads to a greater immune response. Despite the power of HPV vaccination to prevent cervical cancer, only one-third of adolescent girls have completed the 3-dose series. The CDC reports that vaccination coverage increased slightly between 2012 and 2013 with another slight increase between 2013 and 2014, the President’s Cancer Panel released a report calling “underuse of HPV vaccines a serious but correctable threat to progress against cancer”.

What the Roundtable Will Do

The National HPV Vaccination Roundtable develops and implements pilot projects focused on overcoming barriers to HPV vaccination by focusing on five priority areas.

  • Providers – Strengthen HPV vaccination recommendations and decrease missed opportunities.
  • Parents – Educate and raise awareness about the importance of vaccinating males and females ages 11-12 to prevent cancers and to increase acceptance of vaccination against HPV infection.
  • Systems – Address barriers such as the inadequate reimbursement for vaccine administration and the lack of reminder systems.
  • Policies – Maximize access to and opportunities for vaccination (e.g., by considering alternative settings such as pharmacies).
  • Health Disparities – For underserved populations at highest risk for cervical and other HPV-associated cancers, address barriers including cultural factors, distrust of the medical system, and limited access to health care.



HPV Vaccination Initiative Contact Map

The HPV Vaccination Initiative Contact Map provides contact information for various HPV vaccination initiatives. This map provides a visual display of U.S. HPV vaccination uptake initiatives/interventions that is public and searchable by state and organization and project type. For more information on this tool, please contact acs.hpvvacs@cancer.org

HPV Image

For interactive map click here!


HPV Vaccination Clearinghouse Launched

The Provider Training Task Group just launched a publicly accessible website for their HPV Vaccination Resource Clearinghouse, where resources can be found to support the implementation of strategies to increase HPV vaccination. The Clearinghouse features Patient Education Tools and Provider Education Tools, including printable educational materials, vaccine information statements, toolkits, and multimedia to increase HPV vaccination awareness and uptake.


Nation’s Cancer Centers Issue Statement Urging HPV Vaccination

On Wednesday, January 27, 2016, National Cancer Institute (NCI)-designated Cancer Centers across the country simultaneously released a consensus statement urging action to increase vaccination against human papillomavirus (HPV).   More information at cancer.org blog. The HPV Vaccination Roundtable currently has multiple representatives from NCI and several Cancer Centers working on various task groups.


 The HPV Cancer Survivor Organization Database is live!! Please scroll down a little further under the section "Survivorship" for more information and details on how to access it.

HPV Roundtable Steering Committee Members

An 11-member Steering Committee was selected based on their organizations’ involvement in HPV vaccination activities or prevention of HPV-associated cancers, their ability to deliver education or vaccination, or their expertise relevant to expanding HPV vaccination. The Steering Committee provides leadership and vision for the Roundtable to help advance its mission, guides planning and implementation of Roundtable projects, and approves Roundtable membership.

Member Organizations

The National HPV Vaccination Roundtable is a coalition of public, private, and voluntary organizations with expertise relevant to increasing HPV vaccination coverage in the United States as a way to reduce illness and death from HPV-associated cancers, through coordinated leadership, strategic planning, and advocacy.

Members are organizations that designate one representative to serve on the Roundtable. Approximately 75 organizations currently participate. Most of the organizations are national, but some are statewide.

If you are interested in applying for membership, please fill out this survey. Thank you for your interest!, Please understand that due to limitations in meeting space and financial resources, we will not be able to accommodate all qualified requests for membership.

Task Groups

The work of the Roundtable will be primarily implemented through Task Groups. Each Task Group will plan, implement, and evaluate 1-2 pilots projects.

The selection criteria for pilot projects included the following:

  • Responsive – addresses one or more of the five priority areas (providers, parents, systems, policies, and health disparities)
  • Collaborative – involves cancer prevention and immunization as well as other stakeholders
  • Impactful – passes the “so what?” test
  • Feasible – can be completed within one year and with available funds/budget
  • Novel – qualifies as a project that a large coalition of organizations should undertake and that has not previously been done


 The HPV Resource Center provides information, tools, and resources for healthcare professionals, researchers, and others to help increase HPV vaccination rates for males and females at the recommended ages for vaccination.  Get information about the resource center, as well as criteria for submitting resources.

Engaging Survivors to Speak about HPV Related Cancers

The American Cancer Society’s National HPV Vaccination Roundtable is thrilled to introduce a new resource, the HPV Cancer Survivor Organization Database. HPV-related cancer survivors have a unique voice, and inviting a survivor to tell his or her story at a meeting, grand rounds, conference, or other event can be a powerful addition to your program or presentation. We hope that you find this resource useful, and that you are able to include survivors in some of your upcoming events. Many organizations have national networks of speakers, so please contact the person listed in the database if you would like to find out if a national organization has a speaker in your area. Click Here to access the database.

Surv large photo

How can I get Involved?

If you are interested in receiving more information regarding the Roundtable (monthly updates etc.) please fill out our Interest survey:

To Find Out More

Email: HPV.Vaccination.Roundtable@cancer.org